Filing Details
- Accession Number:
- 0001562180-21-006901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-08 19:11:35
- Reporting Period:
- 2021-11-04
- Accepted Time:
- 2021-11-08 19:11:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710072 | Edgewise Therapeutics Inc. | EWTX | Pharmaceutical Preparations (2834) | 821725586 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1853529 | J Alan Russell | C/O Edgewise Therapeutics, Inc. 3145 Colorado Ave. Boulder CO 80303 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-11-04 | 7,392 | $19.76 | 92,278 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-05 | 6 | $20.70 | 92,272 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-05 | 13,036 | $19.62 | 79,236 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 9,017 | $20.16 | 70,219 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.43 to $20.415, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $20.19, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.84 to $20.645, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
